Neuraminidase Inhibitors Drug Market Size, Regional Revenue and Outlook 2025-2034
The global Neuraminidase Inhibitors Drug Market was valued at USD 2.9 billion in 2024 and is expected to exceed USD 5.1 billion by 2034, expanding at a CAGR of over 6.4% throughout the forecast period. This steady growth is fueled by the rising prevalence of seasonal influenza, strengthened pandemic preparedness efforts, and continuous innovations in antiviral drug development.
Neuraminidase Inhibitors Drug Industry Demand